éå»1ã¶æéã«Enlivex Therapeutics Ltdã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã1åã«åºã¥ãããŒã¿ã
仿ãENLVã¯1ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããENLVã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯80.000ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS 114.360ã«ç¶ããENLVã®FY2026Q3ã®EPSã¯-0.280ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
åžå Žäºæ³ã¯ USD 114.36 ã§ããããEnlivex Therapeutics LtdENLV ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 167.84 ã§ãããæ¬¡ã®ååæã® EPS 㯠USD -0.28 ãšäºæ³ãããŸãã